Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News InnoCan Pharma Corporation C.INNO

Alternate Symbol(s):  INNPF

Healthcare Drug Manufacturers - Specialty & Generic
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as... see more

Current News (CSE:INNO)

Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M

Canada NewsWire 10 days ago

Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats

Canada NewsWire 12 days ago

Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model

Canada NewsWire November 20, 2025

CSE Bulletin: MOC Eligibility Update

Newsfile November 14, 2025

Innocan Pharma to Present at the 2025 ThinkEquity Conference

Canada NewsWire October 24, 2025

Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan

Canada NewsWire October 15, 2025

Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

Canada NewsWire September 18, 2025

Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference

Canada NewsWire September 15, 2025

CSE Bulletin: Consolidation - InnoCan Pharma Corporation (INNO)

Newsfile September 2, 2025
View More News ››

Opinion & Analysis (CSE:INNO)

A Look into the Future of Chronic Pain Management

Research January 9, 2025
View More Opinion ››

Bullboard Posts (CSE:INNO)

CEO rating ..

Ghosting after hard efforts to get the attention of our family office. Not sure about mgmt .. 
Valorem - April 8, 2025

What do you think?

Interesting?
Tulsa123 - February 19, 2025

WAKE UP

this is a growth stock.  lots of news coming. do your dd .
longball44 - February 5, 2025

INNO

 we also own 60% of  BI Ski global ltd .  coming to north americian  markets   SOON    $$$
longball44 - February 5, 2025

InnoCan

I think InnoCan has established itself very well. Record sales are expected for 2024. See the news from January 29, 2025 at InnoCan.com....
Joel59 - February 4, 2025

RE:looks like

Hello, InnoCan deserves higher prices see the news from 29.01.2025 Excerpt from the news Yahoo!Finance HERZLIYA, Israel and CALGARY,&...
Joel59 - February 4, 2025
View more Bullboard ››

FPX Nickel Corp.

FPX Nickel Corp.

FPX Nickel Corp., a junior nickel mining company, engages in the acquisition, exploration, and development of mineral ...
View More »